share_log

Hutchmed's Lung Cancer Drug to Remain in China's National Reimbursement Drug List

Hutchmed's Lung Cancer Drug to Remain in China's National Reimbursement Drug List

博龍藥業的肺癌藥物將繼續保留在中國的國家醫保藥品目錄中
MT Newswires ·  2024/11/28 20:31

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論